On the fly News and insights, exclusive to thefly.com

MRTX

Mirati Therapeutics

$154.19 /

-2.41 (-1.54%)

, GRA

W.R. Grace

$68.38 /

+ (+0.00%)

09:56
05/17/21
05/17
09:56
05/17/21
09:56

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mirati Therapeutics (MRTX) downgraded to Perform from Outperform at Oppenheimer with analyst Jay Olson citing potentially significant leadership advantages for Lumakras. 2. W.R. Grace (GRA) downgraded to Market Perform from Outperform at BMO Capital with analyst John McNulty saying that while it's "impossible" to entirely rule out a competing bid to 40North's agreed upon price, with roughly three weeks having passed since W.R. Grace's board and management agreed to sell the company, and considering the length of the negotiation to get to that point, he believes the likelihood of someone coming "over the top" is "relatively low." 3. BRF S.A. (BRFS) downgraded to Underweight from Equal Weight at Barclays with analyst Benjamin Theurer expecting "multiple external headwinds to weigh on fundamentals and stock performance." 4. Zions Bancorp (ZION) downgraded to Underperform from Neutral at Baird. 5. NextEra Energy Partners (NEP) downgraded to Neutral from Buy at Seaport Global with analyst Angie Storozynski saying investors are increasingly discounting growth pipelines of renewable power producers and that it is now prudent to value U.S. yieldcos based on already secured/financed growth projects given the potential for lower project returns and/or a lower PV of future cash flows. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MRTX

Mirati Therapeutics

$154.19 /

-2.41 (-1.54%)

GRA

W.R. Grace

$68.38 /

+ (+0.00%)

BRFS

BRF S.A.

$3.88 /

-0.115 (-2.88%)

ZION

Zions Bancorp

$59.56 /

-0.67 (-1.11%)

NEP

NextEra Energy Partners

$65.65 /

-1.14 (-1.71%)

  • 17

    May

  • 18

    May

  • 19

    May

  • 19

    Jul

  • 19

    Aug

  • 28

    Oct

MRTX Mirati Therapeutics
$154.19 /

-2.41 (-1.54%)

05/17/21 Oppenheimer
Mirati Therapeutics downgraded to Perform from Outperform at Oppenheimer
05/17/21 Oppenheimer
Mirati Therapeutics downgraded to Perform from Outperform at Oppenheimer
05/10/21 Jefferies
Jefferies upgrades Mirati Therapeutics to Buy after 35% pullback
05/10/21 Jefferies
Mirati Therapeutics upgraded to Buy from Hold at Jefferies
GRA W.R. Grace
$68.38 /

+ (+0.00%)

05/14/21 BMO Capital
W.R. Grace downgraded to Market Perform from Outperform at BMO Capital
04/27/21 UBS
W.R. Grace downgraded to Neutral from Buy at UBS
04/27/21 CL King
W.R. Grace downgraded to Neutral from Buy at CL King
04/26/21 Vertical Research
W.R. Grace downgraded to Hold from Buy at Vertical Research
BRFS BRF S.A.
$3.88 /

-0.115 (-2.88%)

05/17/21 Barclays
BRF S.A. downgraded to Underweight from Equal Weight at Barclays
04/22/21 Goldman Sachs
BRF S.A. initiated with a Buy at Goldman Sachs
12/15/20 Grupo Santander
BRF S.A. downgraded to Hold from Buy at Santander
08/06/20 Bradesco BBI
BRF S.A. upgraded to Outperform on processed food gains at Bradesco BBI
ZION Zions Bancorp
$59.56 /

-0.67 (-1.11%)

05/17/21 Baird
Zions Bancorp downgraded to Underperform from Neutral at Baird
04/20/21 Truist
Zions Bancorp price target raised to $70 from $65 at Truist
04/20/21 Baird
Zions Bancorp shares unattractive at current levels, says Baird
04/09/21 Jefferies
Zions Bancorp price target raised to $57 from $52 at Jefferies
NEP NextEra Energy Partners
$65.65 /

-1.14 (-1.71%)

05/17/21 Seaport Global
Seaport downgrades NextEra Energy Partners, 'uncomfortable' about conversion
05/17/21 Seaport Global
NextEra Energy Partners downgraded to Neutral from Buy at Seaport Global
02/12/21 BofA
NextEra Energy Partners downgraded to Underperform from Neutral at BofA
01/27/21 Wells Fargo
NextEra Energy price target raised to $100 from $85 at Wells Fargo

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.